NATIONAL REAL-LIFE STUDY OF LYMPHOMAS FRESH-PEF73987-en Fanny CHERBLANC NATIONAL REAL-LIFE STUDY OF LYMPHOMAS REALYSA FRESH-PEF73987-en 73987 FRESH-PEF73987 Hervé GHESQUIERES Fanny CHERBLANC HOSPICES CIVILS DE LYON (HCL) LYSARC - THE LYMPHOMA ACADEMIC RESEARCH ORGANISATION Epidemiology France Portal (PEF) null Fanny;CHERBLANC Prognostic factors Therapeutic management Biobanks Prospective study Multicentric Environmental exposure Occupational exposure Care pathway Pesticides Hematology Neoplasms of haematopoietic or lymphoid tissues Socio-demographic and economic determinants Behavioral determinants Behavioral determinants: Eating habits Environmental determinants Healthcare system determinants: Use of care Socio-demographic and economic determinants: Employment Healthcare system determinants Set up a real-life epidemiological platform for lymphoma prognosis in France, including epidemiological, clinical and biological data, with prospective follow-up of patients for up to 9 years. null France Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Clinical data Participant-reported health data Biological data Socio-demographic data Paraclinical data (non-biological) : Imaging WHO 2016 diagnostic classification MEDDRA extract for adverse events Data validation within eCRF (queries) consistency test in SAS quality control by sampling with comparison to the source file Other Through organizations (health services or institutions schools businesses etc.) Self-administered questionnaire Interview with the participant (including clinical) Medico-administrative database Observational Study Observational Study Cohort study 6000 Unknown Restricted access All projects must be validated by the REALYSA Scientific Committee and approved by the LYSA Board, on the basis of a synopsis (available on request). The REALYSA Scientific Committee meets quarterly. A contract will be drawn up for each project.